Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study
Authors:
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in The Lancet Global Health
- Vol. 8 (4) , e536-e544
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation (OPP1157270)
This publication has 23 references indexed in Scilit:
- Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic modelsThe Lancet Public Health, 2016
- Human Papillomavirus Vaccination at a Time of Changing Sexual BehaviorEmerging Infectious Diseases, 2016
- Disability weights for the Global Burden of Disease 2013 studyThe Lancet Global Health, 2015
- Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling studyThe Lancet Global Health, 2014
- Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysisCost Effectiveness and Resource Allocation, 2014
- Potential impact of a nine-valent vaccine in human papillomavirus related cervical diseaseInfectious Agents and Cancer, 2012
- A Review of Clinical Trials of Human Papillomavirus Prophylactic VaccinesVaccine, 2012
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publicationInternational Journal of Cancer, 2010
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesVaccine, 2008